Geneos Wealth Management’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,109
Closed -$174K 2669
2025
Q2
$174K Sell
12,109
-15,145
-56% -$211K ﹤0.01% 1049
2025
Q1
$395K Buy
27,254
+24,725
+978% +$372K 0.01% 975
2024
Q4
$38.1K Buy
2,529
+514
+26% +$7.79K ﹤0.01% 1426
2024
Q3
$29.9K Buy
+2,015
New +$28.9K ﹤0.01% 1393
2022
Q3
Sell
-110
Closed -$1K 2153
2022
Q2
$1K Hold
110
﹤0.01% 2474
2022
Q1
$1K Sell
110
-325
-75% -$5.45K ﹤0.01% 2628
2021
Q4
$7K Hold
435
﹤0.01% 2291
2021
Q3
$7K Hold
435
﹤0.01% 2335
2021
Q2
$7K Sell
435
-78
-15% -$1.31K ﹤0.01% 2325
2021
Q1
$8K Hold
513
﹤0.01% 2463
2020
Q4
$7K Sell
513
-222
-30% -$3.17K ﹤0.01% 2350
2020
Q3
$9K Sell
735
-1,300
-64% -$17.9K ﹤0.01% 1972
2020
Q2
$27K Sell
2,035
-320
-14% -$4.27K ﹤0.01% 1486
2020
Q1
$29K Sell
2,355
-4,000
-63% -$64.3K ﹤0.01% 1356
2019
Q4
$113K Hold
6,355
0.01% 903
2019
Q3
$113K Hold
6,355
0.01% 848
2019
Q2
$111K Hold
6,355
0.01% 867
2019
Q1
$114K Hold
6,355
0.01% 817
2018
Q4
$100K Hold
6,355
0.01% 833
2018
Q3
$125K Buy
6,355
+3,745
+143% +$71.8K 0.01% 808
2018
Q2
$48K Sell
2,610
-2,695
-51% -$50.7K ﹤0.01% 1067
2018
Q1
$94K Buy
5,305
+1,310
+33% +$24K 0.01% 772
2017
Q4
$75K Buy
3,995
+1,300
+48% +$23.2K 0.01% 846
2017
Q3
$45K Sell
2,695
-1,725
-39% -$28.8K ﹤0.01% 991
2017
Q2
$73K Hold
4,420
0.01% 790
2017
Q1
$69K Buy
4,420
+625
+16% +$9.78K 0.01% 773
2016
Q4
$56K Buy
3,795
+1,250
+49% +$18.2K 0.01% 799
2016
Q3
$36K Hold
2,545
﹤0.01% 925
2016
Q2
$36K Hold
2,545
0.01% 918
2016
Q1
$36K Buy
+2,545
New +$34.1K 0.01% 900

Other funds holding DIAX

Geneos Wealth Management's DIAX Position: Q3 2025 in Review

Geneos Wealth Management sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q3 2025, closing a stake of 12,109 shares — an estimated $174K sold.

Geneos Wealth Management first reported a position in DIAX in Q1 2016 and held it in 30 quarters. The position peaked at $395K in Q1 2025. 109 funds tracked by Wall St. Rank hold DIAX as of Q3 2025.

  • Geneos Wealth Management reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 12,109 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q3 2025, an estimated $174K.
  • Geneos Wealth Management first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q1 2016 and held it in 30 quarters.
  • Geneos Wealth Management's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $395K in Q1 2025.
  • 109 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.